Foosung (093370) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
18 Mar, 2026Executive summary
Achieved consolidated sales of KRW 471.6 billion in FY2025, up 7.7% year-over-year, with operating income of KRW 25.3 billion, a turnaround from the previous year's loss.
Growth driven by increased refrigerant sales and expansion in chemical equipment sales, especially in North America.
EBITDA reached KRW 66.3 billion, and net income attributable to owners was KRW 5.3 billion, reversing prior losses.
Financial highlights
Consolidated assets totaled KRW 827.5 billion at year-end, with liabilities at KRW 438.1 billion and equity at KRW 389.4 billion.
Gross margin improved to 18.6% from 12.5% year-over-year.
Cash and cash equivalents increased to KRW 67.7 billion, while total borrowings decreased by KRW 89.2 billion to KRW 307.4 billion.
Debt ratio improved to 113% from 148% year-over-year.
Earnings per share (EPS) was KRW 50, compared to a loss of KRW 668 in the prior year.
Outlook and guidance
Management expects continued global economic uncertainty due to geopolitical tensions and inflation, but aims to maintain growth through market responsiveness and operational efficiency.
No specific quantitative guidance provided for FY2026.
Latest events from Foosung
- H1 2024 saw revenue drop 24.8% and an operating loss, but net profit returned after capital raising.093370
Q2 202423 Feb 2026 - Revenue down 37% YoY, net loss narrows, cash up after rights offering and capacity expansion.093370
Q3 202423 Feb 2026 - 2024 saw a 16% revenue drop and net loss amid weak battery and semiconductor demand.093370
Q4 202423 Feb 2026 - H1 2025 revenue rose 4.9% and operating profit turned positive, led by battery and gas segments.093370
Q2 202523 Feb 2026 - Q1 2025 revenue declined 1.3% YoY, with a net loss amid weak battery and semiconductor demand.093370
Q1 202523 Feb 2026 - Revenue up 7.6% YoY, operating income positive, net loss narrowed, and capital raised for growth.093370
Q3 202523 Feb 2026